|
BNIP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.0767999975877E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.19760000033753E-07 |
| Normal-vs-Stage2 |
3.799100E-03 |
| Normal-vs-Stage3 |
1.01300000054927E-07 |
| Normal-vs-Stage4 |
1.853980E-02 |
| Stage1-vs-Stage2 |
7.023400E-01 |
| Stage1-vs-Stage3 |
3.689600E-01 |
| Stage1-vs-Stage4 |
9.773800E-01 |
| Stage2-vs-Stage3 |
3.222400E-01 |
| Stage2-vs-Stage4 |
7.958600E-01 |
| Stage3-vs-Stage4 |
7.078200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.53249976545078E-10 |
| Normal-vs-AfricanAmerican |
3.289800E-01 |
| Normal-vs-Asian |
8.267500E-02 |
| Caucasian-vs-AfricanAmerican |
1.572200E-02 |
| Caucasian-vs-Asian |
9.803700E-02 |
| AfricanAmerican-vs-Asian |
6.776200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.061600E-03 |
| Normal-vs-Female |
2.20679996498774E-09 |
| Male-vs-Female |
6.256200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.49180000000604E-05 |
| Normal-vs-Age(41-60Yrs) |
4.47129999692208E-09 |
| Normal-vs-Age(61-80Yrs) |
2.996700E-04 |
| Normal-vs-Age(81-100Yrs) |
8.376200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.432400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.255800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.215390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.895200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.441410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.226180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.764500E-04 |
| Classical-VS-Follicular |
7.421500E-02 |
| Classical-VS-Other |
6.171400E-01 |
| Classical-VS-Normal |
1.12389999973317E-07 |
| Tall-VS-Follicular |
1.602660E-04 |
| Tall-VS-Other |
1.705510E-02 |
| Tall-VS-Normal |
1.00169983419107E-10 |
| Follicular-VS-Other |
8.361400E-01 |
| Follicular-VS-Normal |
7.124300E-02 |
| Other-VS-Normal |
1.112010E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.94240000000501E-05 |
| Normal-vs-N1 |
1.029300E-04 |
| N0-vs-N1 |
3.503800E-01 |
|
|
